IDO1 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), the IDO1–kynurenine pathway fosters naïve T cell conversion into Tregs (32), while tumor-derived IL-37 polarizes macrophages toward a suppressive phenotype, correlating with elevated Treg presence and reduced NK activity (33).